-
1دورية أكاديمية
المؤلفون: Akiko Matsumoto, Chiho Nakashima, Shinya Kimura, Eizaburo Sueoka, Naoko Aragane
المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
مصطلحات موضوعية: ALDH2, rs671, Immune checkpoint inhibitors, Thoracic malignancy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1471-2407
-
2دورية أكاديمية
المؤلفون: Makoto Okuda, Yutaka Nagura, Koji Kishino, Naohito Itami, Kenichi Kushibiki, Hiroko Kuribayashi, Mina Komoto, Kohei Saito, Tatsuya Sugimoto, Junichi Terauchi, Akito Nozaki, Shinji Yoshii, Ayako Endo, Tadatsugu Sato, Eizaburo Sueoka, Masayuki Suzuki, Koki Takahashi, Yoko Hidaka, Motohiro Fujii, Kaoru Yashiro
المصدر: Japanese Journal of Transfusion & Cell Therapy / Nihon Yuketsu Saibo Chiryo Gakkaishi; 2024, Vol. 70 Issue 1, p7-11, 5p
مصطلحات موضوعية: BLOOD transfusion, COMPUTER systems
-
3
المؤلفون: Eizaburo Sueoka, Naoko Aragane, Akiko Matsumoto, Chiho Nakashima, Shinya Kimura
المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancerمصطلحات موضوعية: Adult, Male, 0301 basic medicine, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Programmed Cell Death 1 Receptor, Adenocarcinoma of Lung, Thoracic malignancy, Pembrolizumab, Gastroenterology, B7-H1 Antigen, 03 medical and health sciences, Immune checkpoint inhibitors, 0302 clinical medicine, Atezolizumab, Internal medicine, Genetics, medicine, Humans, RC254-282, Aged, ALDH2, Aged, 80 and over, business.industry, Research, Aldehyde Dehydrogenase, Mitochondrial, Hazard ratio, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, medicine.disease, Progression-Free Survival, Tumor antigen, rs671, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Adenocarcinoma, Female, Nivolumab, PD-L1 inhibitor, business, Progressive disease
-
4
المؤلفون: Naoko Aragane, Chiho Nakashima, Akiko Matsumoto, Shinya Kimura, Eizaburo Sueoka
مصطلحات موضوعية: Text mining, business.industry, Polymorphism (computer science), Immune checkpoint inhibitors, Cancer research, Medicine, business, ALDH2
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c730bc657281cc1476571822d746cb4e
https://doi.org/10.21203/rs.3.rs-257337/v1 -
5
المؤلفون: Yu Matsuzaki, Takao Orii, Michio Kimura, Yoshiaki Uyama, Masaharu Nakayama, Mayuko Ujibe, Yoshiaki Fujimura, Hideto Yokoi, Kazuhiko Ohe, Takahiro Suzuki, Mari Kishiba, Fumitaka Takahashi, Koichiro Murata, Sayoko Harada, Eizaburo Sueoka, Naoki Nakashima, Mitsune Yamaguchi, Maiko Kawaguchi, Satomi Inomata
المصدر: Pharmacoepidemiology and Drug Safety
مصطلحات موضوعية: drug safety, Databases, Factual, Drug-Related Side Effects and Adverse Reactions, Epidemiology, media_common.quotation_subject, Best practice, Medical information, computer.software_genre, 030226 pharmacology & pharmacy, MID‐NET®, 03 medical and health sciences, Pharmacovigilance, 0302 clinical medicine, Japan, Health care, Original Reports, Product Surveillance, Postmarketing, Medicine, Original Report, data quality, Electronic Health Records, Humans, Pharmacology (medical), 030212 general & internal medicine, media_common, Data Management, Database, business.industry, medical information database, Clinical Coding, Reproducibility of Results, real‐world data, Quality management system, Data quality, regulatory science, Data center, business, computer, Welfare, Coding (social sciences)
-
6
المؤلفون: Maori Itoh, Koichiro Murata, Hideto Yokoi, Chieko Ishiguro, Naoki Nakashima, Yoshiaki Uyama, Eizaburo Sueoka, Takao Orii, Michio Kimura, Masaharu Nakayama, Yoshiaki Fujimura, Kazuhiko Ohe, Takahiro Suzuki, Kaori Yamada
المصدر: Pharmacoepidemiology and Drug Safety. 28:601-608
مصطلحات موضوعية: Drug, Drug Utilization, Health professionals, Database, Epidemiology, business.industry, media_common.quotation_subject, MEDLINE, Medical information, Pharmacoepidemiology, computer.software_genre, 030226 pharmacology & pharmacy, 03 medical and health sciences, 0302 clinical medicine, Medicine, Pharmacology (medical), Regulatory science, 030212 general & internal medicine, Medical prescription, business, computer, media_common
-
7GUIDELINE FOR THE USE OF RED BLOOD CELL PRODUCTS BASED ON SCIENTIFIC EVIDENCE (REVISION 2ND EDITION)
المؤلفون: Eiichi Inada, Takashi Sonoki, Yasunori Ueda, Kazuhiro Nagai, Midori Kumakawa, Eizaburo Sueoka, Naohito Fujishima, Takahiko Kubo, Tadashi Matsushita, Masanori Matsumoto, Yuji Yonemura, Kohshi Ohishi
المصدر: Japanese Journal of Transfusion and Cell Therapy. 64:688-699
مصطلحات موضوعية: Cultural Studies, Red blood cell, medicine.medical_specialty, medicine.anatomical_structure, business.industry, medicine, Guideline, Intensive care medicine, business, Education, Scientific evidence
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4afb6abb32f1b89ea90a075c942d2199
https://doi.org/10.3925/jjtc.64.688 -
8
-
9
المؤلفون: Chinatsu, Komatsu, Megumi, Oho, Kouji, Kusaba, Seiji, Kawasaki, Nohara, Tsukamoto, Yuya, Hirata, Yoshihiro, Nagasawa, Yumiko, Funashima, Zenzo, Nagasawa, Eizaburo, Sueoka
المصدر: Rinsho Biseibutsu Jinsoku Shindan Kenkyukai shi = JARMAM : Journal of the Association for Rapid Method and Automation in Microbiology. 29(2)
مصطلحات موضوعية: Bacterial Proteins, Enterobacteriaceae, Enterobacteriaceae Infections, Humans, beta-Lactamases, Anti-Bacterial Agents, Culture Media
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::dfefc9faa5f820e2b539084838938aa3
https://pubmed.ncbi.nlm.nih.gov/32312080 -
10
المؤلفون: Kaori, Yamada, Maori, Itoh, Yoshiaki, Fujimura, Michio, Kimura, Koichiro, Murata, Naoki, Nakashima, Masaharu, Nakayama, Kazuhiko, Ohe, Takao, Orii, Eizaburo, Sueoka, Takahiro, Suzuki, Hideto, Yokoi, Chieko, Ishiguro, Yoshiaki, Uyama
المصدر: Pharmacoepidemiology and drug safety. 28(5)
مصطلحات موضوعية: Drug-Related Side Effects and Adverse Reactions, Japan, Databases, Pharmaceutical, Risk Factors, Incidence, Pharmacoepidemiology, Product Surveillance, Postmarketing, Adverse Drug Reaction Reporting Systems, Pilot Projects, Drug Utilization